About TEVA-MYCOPHENOLATE

TEVA-MYCOPHENOLATE is a prescription medication containing the active ingredient Mycophenolate Mofetil, used to prevent rejection in organ transplant patients. It belongs to a class of drugs known as immunosuppressants, which work by suppressing the body's immune system to prevent it from attacking the transplanted organ.

Key Benefits & Uses

Prevention of organ rejection in kidney, liver, and heart transplant patients
Treatment of rheumatoid arthritis and other autoimmune diseases
Prevention of graft-versus-host disease in bone marrow transplant patients

Active Ingredient & Action

Mycophenolate Mofetil is a prodrug that is converted into its active form, Mycophenolic acid, in the body. Mycophenolic acid works by inhibiting the enzyme inosine monophosphate dehydrogenase (IMPDH), which is necessary for the production of guanosine nucleotides. This action suppresses the proliferation of T and B lymphocytes, which are key components of the immune system.

Important Notes

TEVA-MYCOPHENOLATE should only be used under the guidance of a healthcare professional. It may cause side effects such as nausea, vomiting, diarrhea, and increased risk of infections. Patients taking TEVA-MYCOPHENOLATE should have regular blood tests to monitor their liver and kidney function, as well as their blood cell counts.